Adma Biologics (ADMA) Deferred Taxes (2011 - 2025)

Adma Biologics' (ADMA) quarterly Deferred Taxes came in at -$20.9 million in Q4 2025, down 124.76% YoY from $84.3 million in Q4 2024, and down 534.48% on a QoQ basis from $4.8 million in Q3 2025.

Adma Biologics (ADMA) Deferred Taxes (2011 - 2025) Analysis & Trends

Adma Biologics (ADMA) has 7 years of Deferred Taxes data on file, last reported at -$20.9 million in Q4 2025.

  • Quarterly Deferred Taxes fell 124.76% year-over-year to -$20.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$11.0 million (down 113.08% YoY) and the FY2025 annual result came in at -$11.0 million, down 113.08% from the prior year.
  • Deferred Taxes eased to -$20.9 million in Q4 2025, from $4.8 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $84.3 million in Q4 2024 to a low of -$20.9 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -69.70 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 194.40 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -137,876.64
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 2.66 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Adma Biologics 2.13 Bn 2.00 Bn 86.28 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -20.87 Mn
Sep 30, 2025 4.80 Mn
Jun 30, 2025 1.62 Mn
Mar 31, 2025 3.43 Mn
Dec 31, 2024 84.28 Mn
Mar 31, 2017 -7,640.00
Mar 31, 2016 -7,640.00
Mar 31, 2013 -5,548.00
Dec 31, 2012 -5,548.00
Sep 30, 2012 -5,547.00
Jun 30, 2012 -5,548.00
Mar 31, 2012 -5,547.00
Dec 31, 2011 -5,548.00
Sep 30, 2011 -5,547.00
Jun 30, 2011 -8,518.00
Mar 31, 2011 -2,577.00